まとめグローバルキメラ抗原受容体細胞療法市場は、2015年から2019年までのCAGR xx％でxxx百万米ドルと評価されました。 その後、2020年にはXXX百万米ドルに達し、2020年から2025年までのCAGRはxx％になります。
世界のキメラ抗原受容体細胞療法市場では、このレポートは特に北アメリカ、南アメリカ、ヨーロッパとアジア太平洋、および中東とアフリカに焦点を当てています。 このレポートは、アプリケーション、タイプ、地域、および製造業者に基づいて市場を分類します。
メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）
タイプによる市場細分化：
単独療法
併用療法
アプリケーションによる市場細分化：
急性白血病
非ホジキンリンパ腫
多発性骨髄腫
移植拒絶
他の
この調査は、次の重要な質問に対する回答を提供します。
• 2020年から2025年の予測期間におけるキメラ抗原受容体細胞療法市場の推定成長率と市場シェアおよび規模はどのくらいですか？
• 予測期間2020年から2025年のキメラ抗原受容体細胞療法市場の原動力は何ですか？
• 著名なマーケットプレーヤーは誰ですか？彼らは他の競合他社に対してどのように競争力を獲得しましたか？
• 世界中のキメラ抗原受容体細胞療法の業界の進歩に影響を与える市場動向は何ですか？
• 業界の進歩を制限する主な課題と脅威は何ですか？
• 市場は著名な市場プレーヤーにとってどのような機会を持っていますか？
このレポートに関する特別な要件がある場合は、お知らせください。カスタムレポートを提供できます。
注–より正確な市場予測を提供するために、COVID-19の影響を考慮して、すべてのレポートが配信前に更新されます。
Table of Contents
1 Chimeric Antigen Receptor Cell Therapy Market Overview
1.1 Product Overview and Scope of Chimeric Antigen Receptor Cell Therapy
1.2 Classification of Chimeric Antigen Receptor Cell Therapy by Types
1.2.1 Global Chimeric Antigen Receptor Cell Therapy Revenue Comparison by Types (2020-2025)
1.2.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Types in 2018
1.2.3 Monotherapy
1.2.4 Combination Therapy
1.3 Global Chimeric Antigen Receptor Cell Therapy Market by Application
1.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size and Market Share Comparison by Applications (2015-2025)
1.3.2 Acute Leukemia
1.3.3 Non-hodgkins Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Transplant Rejection
1.3.6 Other
1.4 Global Chimeric Antigen Receptor Cell Therapy Market by Regions
1.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size (Million USD) Comparison by Regions (2015-2025)
1.4.1 North America (USA, Canada and Mexico) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2015-2025)
1.4.4 South America (Brazil, Argentina, Colombia) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2015-2025)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2015-2025)
1.5 Global Market Size of Chimeric Antigen Receptor Cell Therapy (2015-2025)
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Business Overview
2.1.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.2 Autolus Therapeutics Plc
2.2.1 Business Overview
2.2.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.3 Beijing Immunochina Medical Science & Technology Co Ltd
2.3.1 Business Overview
2.3.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.4 Bellicum Pharmaceuticals Inc
2.4.1 Business Overview
2.4.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.5 Bristol-Myers Squibb Co
2.5.1 Business Overview
2.5.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.6 bluebird bio Inc
2.6.1 Business Overview
2.6.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.7 CARsgen Therapeutics Ltd
2.7.1 Business Overview
2.7.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.8 Celgene Corp
2.8.1 Business Overview
2.8.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.9 Cell Medica Ltd
2.9.1 Business Overview
2.9.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.10 Cellular Biomedicine Group Inc
2.10.1 Business Overview
2.10.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.11 Celularity Inc
2.11.1 Business Overview
2.11.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.12 Celyad SA
2.12.1 Business Overview
2.12.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.13 Daiichi Sankyo Co Ltd
2.13.1 Business Overview
2.13.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.14 Fosun Pharmaceutical AG
2.14.1 Business Overview
2.14.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.15 Gilead Sciences Inc
2.15.1 Business Overview
2.15.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.16 Guangzhou Anjie Biomedical Technology Co Ltd
2.16.1 Business Overview
2.16.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.17 Hangzhou Converd Co Ltd
2.17.1 Business Overview
2.17.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.18 Hebei Senlang Biotechnology Inc Ltd
2.18.1 Business Overview
2.18.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.19 HRAIN Biotechnology Co Ltd
2.19.1 Business Overview
2.19.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.20 Juno Therapeutics Inc
2.20.1 Business Overview
2.20.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.21 Kite Pharma Inc
2.21.1 Business Overview
2.2.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.22 Nanjing Legend Biotech Co Ltd
2.22.1 Business Overview
2.22.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.23 NantKwest Inc
2.23.1 Business Overview
2.23.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.24 Nkarta Inc
2.24.1 Business Overview
2.24.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.25 Novartis AG
2.25.1 Business Overview
2.25.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.26 Ono Pharmaceutical Co Ltd
2.26.1 Business Overview
2.26.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
2.27.1 Business Overview
2.27.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.28 Sorrento Therapeutics Inc
2.28.1 Business Overview
2.28.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.29 Takara Bio Inc
2.29.1 Business Overview
2.29.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
3 Global Chimeric Antigen Receptor Cell Therapy Market Competition, by Players
3.1 Global Chimeric Antigen Receptor Cell Therapy Revenue and Share by Players (2015-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Chimeric Antigen Receptor Cell Therapy Players Market Share
3.2.2 Top 10 Chimeric Antigen Receptor Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions
4.1 Global Chimeric Antigen Receptor Cell Therapy Revenue and Market Share by Regions
4.2 North America Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
4.3 Europe Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
4.4 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
4.5 South America Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
4.6 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
5 North America Chimeric Antigen Receptor Cell Therapy Revenue by Countries
5.1 North America Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2015-2019)
5.2 USA Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
5.3 Canada Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
5.4 Mexico Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
6 Europe Chimeric Antigen Receptor Cell Therapy Revenue by Countries
6.1 Europe Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2015-2019)
6.2 Germany Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
6.3 UK Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
6.4 France Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
6.5 Russia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
6.6 Italy Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
7 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue by Countries
7.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2015-2019)
7.2 China Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
7.3 Japan Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
7.4 Korea Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
7.5 India Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
7.6 Southeast Asia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
8 South America Chimeric Antigen Receptor Cell Therapy Revenue by Countries
8.1 South America Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2015-2019)
8.2 Brazil Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
8.3 Argentina Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
8.4 Colombia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
9 Middle East and Africa Revenue Chimeric Antigen Receptor Cell Therapy by Countries
9.1 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2015-2019)
9.2 Saudi Arabia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
9.3 UAE Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
9.4 Egypt Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
9.5 Nigeria Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
9.6 South Africa Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2015-2019)
10 Global Chimeric Antigen Receptor Cell Therapy Market Segment by Type
10.1 Global Chimeric Antigen Receptor Cell Therapy Revenue and Market Share by Type (2015-2019)
10.2 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Type (2020-2025)
10.3 Monotherapy Revenue Growth Rate (2015-2025)
10.4 Combination Therapy Revenue Growth Rate (2015-2025)
11 Global Chimeric Antigen Receptor Cell Therapy Market Segment by Application
11.1 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Application (2015-2019)
11.2 Chimeric Antigen Receptor Cell Therapy Market Forecast by Application (2020-2025)
11.3 Acute Leukemia Revenue Growth (2015-2019)
11.4 Non-hodgkins Lymphoma Revenue Growth (2015-2019)
11.5 Multiple Myeloma Revenue Growth (2015-2019)
11.6 Transplant Rejection Revenue Growth (2015-2019)
11.7 Other Revenue Growth (2015-2019)
12 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast (2020-2025)
12.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast (2020-2025)
12.2 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Regions (2020-2025)
12.3 North America Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2020-2025)
12.4 Europe Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2020-2025)
12.5 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2020-2025)
12.6 South America Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2020-2025)
12.7 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2020-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
